Success Stories: With only 8 citations, North America Immigration Law Group Aids an Internal Medicine Resident from the Dominican Republic Obtain NIW Status Without RFE

Client’s Testimonial:

“Thanks very much to the whole team for the assistance and hard work.”

On October 28^th, 2022, we received another EB-2 NIW (National Interest Waiver) approval for an Internal Medicine Resident in the Field of Nephrology (Approval Notice).

General Field: Nephrology

Position at the Time of Case Filing: Internal Medicine Resident

Country of Origin: Dominican Republic

State of Residence at the Time of Filing: New York

Approval Notice Date: October 28^th, 2022

Processing Time: 3 months, 14 day

Case Summary:

“Given that kidney disorders, both chronic and acute, are becoming a significant problem for large numbers of the global population, understanding its impact in the presence of other diseases or conditions is paramount. [The client’s] work has directly addressed this issue, both in the context of complement-mediated pregnancy disorders that affect the kidneys and in the context of infectious diseases such as COVID-19, marking her out among her peers for her beneficial contributions to global public health.”

“[The client], the subject of this letter, is one of the well-known nephrologists in the field investigating the relationship between kidney disease, acute kidney injury, and their complications in the presence of pregnancy and infectious diseases. [Client’s] research is critical for helping clinicians around the country manage complications with kidney disease and prevent this underlying condition from causing poor health outcomes in the United States.”

These are excerpts from letters of recommendation written for an expert in the field of nephrology from the Dominican Republic. She had come to us in April of 2022 seeking help with her NIW (National Interest Waiver) petition. Her proposed endeavor was to continue her research on improving the management and implementation of care for patients with chronic kidney disease and related conditions in order to improve health outcomes and reduce healthcare expenditures. Thus, it was clear that her research was of great importance because it provides an avenue for reducing the mortalities and costs associated with major diseases including kidney disease and COVID-19.

In her research, our client has performed critical research on the pathogenesis of kidney disease and the factors driving its effective treatment and severity including the association of COVID-19 and kidney disease. Her efforts, therefore, provide a basis for reducing the global burden of kidney disease on public health. Her proposed endeavor also has broad implications for the United States since according to the United States Centers for Disease Control and Prevention, over 1 in 7 or approximately 37 million adults in the United States currently have chronic kidney disease.

On the other hand, her research has resulted in 3 peer-reviewed journal articles (2 of them first-authored) and these papers have been cited at least 8 times already. This meant that she is actively engaged in experiments within and without the laboratory. Thus, her work also represents progress toward her larger goal of advancing the management and implementation of care for patients with chronic kidney disease and related conditions. At the same time, she plans to hold a position that is narrowly tailored to her unique skill set.

All of these factors weighed in during the adjudication process, winning her the NIW approval quickly. We thank her for choosing our firm and wish her the very best.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.